We investigate cancer diagnoses and treatments by means of a combinatorial strategy of animal experiments and clinical information.
Animal experiments are often required in order to bring the in vitro results into the clinical fronts.
Our researches involve therapeutic evaluation of anti-cancer drugs, development of immunotherapy, and identification of novel tumor markers through animal experiments. They also involve creating tumor model mice with specific gene mutations for developing new treatment methods.
We select genes with high incidences in embryonic tissues when compared with those in adult tissues. If the genes are identified with high incidence rates also in tumor tissues, they will be developed as new tumor marker candidates.
In collaboration with the other divisions, we are carrying out animal experiments to develop novel cancer drugs.
We create genetically engineered mice for human tumor models with specific inheritable gene modifications.
